Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence h...
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-08-19/merck-moderna-stocks-soar-after-melanoma-trial-success-video)